Page last updated: 2024-10-23

berberine and Bile Duct Cancer

berberine has been researched along with Bile Duct Cancer in 2 studies

Research Excerpts

ExcerptRelevanceReference
"In present study, a novel phospholipid complex loaded cucurbitacin B modified with berberine hydrochloride (CUB-PLC-BER) was prepared by a simple solvent evaporation method with the aim of improving bile duct-targeted drug delivery and therapeutic efficacy for cholangiocarcinoma (CC)."7.81Improve bile duct-targeted drug delivery and therapeutic efficacy for cholangiocarcinoma by cucurbitacin B loaded phospholipid complex modified with berberine hydrochloride. ( Cheng, L; Han, J; Li, JJ; Liu, CY; Qiu, L; Shen, BD; Shen, G; Xu, PH; Yuan, HL, 2015)
"In present study, a novel phospholipid complex loaded cucurbitacin B modified with berberine hydrochloride (CUB-PLC-BER) was prepared by a simple solvent evaporation method with the aim of improving bile duct-targeted drug delivery and therapeutic efficacy for cholangiocarcinoma (CC)."3.81Improve bile duct-targeted drug delivery and therapeutic efficacy for cholangiocarcinoma by cucurbitacin B loaded phospholipid complex modified with berberine hydrochloride. ( Cheng, L; Han, J; Li, JJ; Liu, CY; Qiu, L; Shen, BD; Shen, G; Xu, PH; Yuan, HL, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Obchoei, S1
Detarya, M1
Boonnate, P1
Saranaruk, P1
Vaeteewoottacharn, K1
Mahalapbutr, P1
Okada, S1
Wongkham, S1
Cheng, L1
Xu, PH1
Shen, BD1
Shen, G1
Li, JJ1
Qiu, L1
Liu, CY1
Yuan, HL1
Han, J1

Other Studies

2 other studies available for berberine and Bile Duct Cancer

ArticleYear
Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor.
    Asian Pacific journal of cancer prevention : APJCP, 2022, Oct-01, Volume: 23, Issue:10

    Topics: Antineoplastic Agents; Berberine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; C

2022
Improve bile duct-targeted drug delivery and therapeutic efficacy for cholangiocarcinoma by cucurbitacin B loaded phospholipid complex modified with berberine hydrochloride.
    International journal of pharmaceutics, 2015, Jul-15, Volume: 489, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Berberine; Bile; Bile Duct Neoplasms; Bile Ducts; Cell Line, Tumor;

2015